Please login to the form below
rheumatology
This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.
GSK pushes rheumatoid arthritis antibody into phase 3
It has taken the decision to push otilimab into phase 3 on the strength of the mid-stage BAROQUE trial, which was reported at the American College of Rheumatology (ACR) congress
Latest news
-
FDA clears Dupixent as first-ever drug for chronic rhinosinusitis with nasal polyps
Nasal polyps can lead to loss of smell and often patients require surgery to remove the polyps,” said the agency’s head of pulmonary, allergy and rheumatology products Sally Seymour.
-
AbbVie’s upadacitinib tops Humira again in arthritis trial
The lead investigator in the SELECT-EARLY trial, Prof Ronald van Vollenhoven of the Amsterdam Rheumatology and Immunology Centre in the Netherlands, said that while remission is the primary treatment goal
-
Novartis forges AI alliance with Oxford University
It says the Oxford University alliance will be “transformative for how Novartis adopts data science at scale from multiple data sources, beginning with flagship programmes in multiple sclerosis, dermatology and rheumatology.”
-
US ‘unicorn’ Samumed on track with lead arthritis drug
The San Diego company presented data at this week’s American College of Rheumatology (ACR) meeting showing that a single injection of SM04690 into the joints of people with OA of
-
Gilead and Galapagos JAK contender scores in RA trial
The FINCH 2 trial of filgotinib in adults with moderately-to-severely active rheumatoid arthritis achieved its primary endpoint in the proportion of patients achieving an American College of Rheumatology 20%
More from news
Approximately 1 fully matching, plus 72 partially matching documents found.
Latest Intelligence
-
NHS regional footprints
For example, the CCG has contracted services for musculoskeletal disorders (MSK), from the Nottinghamshire Integrated Care Partnership (ICP), which is now delivering services around rheumatology, arthritis, physiotherapy, imaging, primary care
-
Case study: Immunology education
There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic (Manchester Royal
-
Pharma deals during April 2014
proteinuria associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms. Whilst this is a 60-year old drug acquired by Questcor in 2001 for $100, 000, generic competition is
-
Pharma deals during February 2014
in litigation over two synthetic versions of Acthar (ACTH), a corticotropin with 19 indications, many in rare diseases including infantile spasms, MS, nephrology, and rheumatology.
-
Interview: Pierre Chancel, Sanofi Diabetes
Marketing Director Theraplix, Rhône-Poulenc. Business Unit Manager for CNS, Rheumatology and HRT, Rhône-Poulenc.
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Amgen appoints senior VP and head of the European region
Merck Serono, where she was senior VP of strategy and global marketing for neurology, rheumatology and immunology.
-
Bone Therapeutics looks to Pfizer for clinical head
Heynen is a specialist in rheumatology and immunology, with over 35 years of experience in medical and regulatory affairs at local, regional and international levels.
-
Aurora expands its team with three new hires
Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and
-
Genentech’s Sunil Agarwal joins rare disease firm
He spent just over 10 years at Genentech where his positions included senior VP for immunology and infectious diseases and VP for rheumatology.
-
Voltarra names new CEO
In his new role, he leads a company with a pipeline of drugs for rheumatology, central nervous system oncology and immunology.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK
Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.
-
Bringing the NHS into the 21st century
We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.
-
Healthcircle
Rx &Medical Devices. Oncology. Haematology. Rheumatology. Anti-infectives. Anti-virals. Cardiovascular. Respiratory. Endocrinology.
-
IGNIFI
Our diverse experience in human and animal health includes:. gastroenterology . rheumatology .
-
The Biosimilar Challenge
In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of biosimilars across a range of therapy areas – especially in rheumatology. ... The pressure is now on to undertake the same in rheumatology, dermatology and
More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.
Featured jobs
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
